Literature DB >> 18766404

Distal bowel surgical margin shorter than 1 cm after preoperative radiation for rectal cancer: is it safe?

Andrzej Rutkowski1, Krzysztof Bujko, Marek P Nowacki, Ewa Chmielik, Anna Nasierowska-Guttmejer, Andrzej Wojnar.   

Abstract

BACKGROUND: The primary end-point of our randomized trial was sphincter preservation. The secondary aim was to evaluate whether distal bowel clearance < or =1 cm is safe after radiation.
METHODS: The study randomized 312 patients with cT3-4 resectable low-lying and mid-rectal cancer to receive either preoperative irradiation (5 x 5 Gy) with immediate total mesorectal excision (TME) or chemoradiation (50.4 Gy, bolus 5-fluorouracil and leucovorin) with delayed TME. After anterior resection, pathologists prospectively measured macroscopic and microscopic distal bowel clearance.
RESULTS: Macroscopic and microscopic distal bowel clearance, distal intramural spread, sphincter preservation, local control, disease-free survival, and overall survival did not differ in the two randomized groups. Pooled analysis of the two groups showed that the incidence of local recurrence at 4 years (median follow-up) for patients with macroscopic clearance < or =1 cm (n = 42) and >1 cm (n = 124) was 11.3% and 15.4%, respectively (P = 0.514); the hazard ratio (HR) was 0.70, and the 95% confidence interval (CI) was 0.23-2.07. The corresponding values for patients with microscopic clearance < or =1 cm (n = 51) and >1 cm (n = 101) were 9.6% and 17.6% (P = 0.220; HR 0.51; 95% CI 0.17-1.53).
CONCLUSION: After preoperative radiotherapy, distal bowel clearance < or =1 cm did not compromise local control.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18766404     DOI: 10.1245/s10434-008-0125-6

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  26 in total

Review 1.  Multidisciplinary management in rectal cancer.

Authors:  Asunción Hervás Morón; María Luisa García de Paredes; Eduardo Lobo Martínez
Journal:  Clin Transl Oncol       Date:  2010-12       Impact factor: 3.405

2.  10-Year Oncologic Outcomes After Laparoscopic or Open Total Mesorectal Excision for Rectal Cancer.

Authors:  Marco E Allaix; Giuseppe Giraudo; Alessia Ferrarese; Alberto Arezzo; Fabrizio Rebecchi; Mario Morino
Journal:  World J Surg       Date:  2016-12       Impact factor: 3.352

3.  A Prospective Study of Distal Microscopic Spread in Rectal Cancer After Neoadjuvant Chemoradiation in Pinned and Unpinned Specimen.

Authors:  Aravind S Kapali; K Chandramohan; A V Jayasudha
Journal:  Indian J Surg Oncol       Date:  2017-03-18

4.  The clinical significance of distal spread differs according to the primary tumor location in rectal cancer.

Authors:  Kaoru Abe; Yoshifumi Shimada; Hidehito Oyanagi; Ryoma Yagi; Masato Nakano; Hitoshi Kameyama; Hitoshi Nogami; Satoshi Maruyama; Yasumasa Takii; Toshifumi Wakai
Journal:  Surg Today       Date:  2019-09-30       Impact factor: 2.549

5.  The new approach to the rectal cancer: 'down-to-up' double endolaparoscopic pelvic access. Preliminary evaluation of outcomes.

Authors:  Dario Borreca; Alberto Bona; Maria Paola Bellomo; Andrea Borasi; Paolo De Paolis
Journal:  Updates Surg       Date:  2015-06-25

Review 6.  Adequate length of the distal resection margin in rectal cancer: from the oncological point of view.

Authors:  In Ja Park; Jin Cheon Kim
Journal:  J Gastrointest Surg       Date:  2010-02-09       Impact factor: 3.452

7.  Impact of Length of Distal Margin on Outcomes Following Sphincter Preserving Surgery for Middle and Lower Third Rectal Cancers.

Authors:  Rahul Bhamre; Abhishek Mitra; Anup Tamankar; Ashwin Desouza; Avanish Saklani
Journal:  Indian J Surg Oncol       Date:  2019-02-09

Review 8.  Evolving treatment strategies for colorectal cancer: a critical review of current therapeutic options.

Authors:  Daniel C Damin; Anderson R Lazzaron
Journal:  World J Gastroenterol       Date:  2014-01-28       Impact factor: 5.742

Review 9.  Distal dissection in total mesorectal excision, and preoperative chemoradiotherapy and lateral lymph node dissection for rectal cancer.

Authors:  Jin-ichi Hida; Kiyotaka Okuno; Tadao Tokoro
Journal:  Surg Today       Date:  2013-12-22       Impact factor: 2.549

10.  Close distal margins do not increase rectal cancer recurrence after sphincter-saving surgery without neoadjuvant therapy.

Authors:  Jason Wei-Min Lim; Min-Hoe Chew; Kiat-Hon Lim; Choong-Leong Tang
Journal:  Int J Colorectal Dis       Date:  2012-08-24       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.